Tech Company Financing Transactions
Xcell Biosciences Funding Round
Xcell Biosciences, based in San Francisco, received $12 million in investment from HBM Healthcare Investments and private investors.
Transaction Overview
Company Name
Announced On
2/17/2017
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
HBM Healthcare Investments (Lead Investor) (Saeid Akhtari)
Proceeds Purpose
Xcell Bio will use the funds to launch its commercial platform worldwide, including expanding its US sales force and worldwide commercial reach.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
455 Mission Bay Blvd. South
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Website
Email Address
Overview
Xcell Biosciences, Inc., is developing revolutionary products and workflows that empower scientists in important fields including cancer research, immunology, stem cell biology, and cell therapy development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Feth
Chief Operating Officer
Janette Phi
Chief Scientific Officer
James Lim
Browse more venture capital transactions:
Prev: 2/17/2017: Mylestone venture capital transaction
Next: 2/17/2017: Dermata Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs